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Figure 1a. Asp conidia attenuates IL6 response in presence of TLR2/TLR4
ligands. Attenuated response only with TLR4 ligand in Asp hyphae.
Figure 1b. TNF production not attenuated by Asp conidia in contrast to IL6.
Decreased TNF response with TLR4 ligand in Asp hyphae.
ligand stimulation. TNF production remained unchanged (Figures
1a & b).
The observed TLR-2 modulation involved phagocytosis, as addition
of cytochalasin B reversed the observed attenuation, while no in-
fluence was seen by signalling through TLR4. This effect was not
mediated by dectin-1 receptor. IL-1b mRNA expression decreased
in response to Aspergillus conidia. TNF, TLR2 and TLR4 mRNA ex-
pression was not significantly attenuated after exposure to As-
pergillus.
Conclusions: We elicited a novel phenomenon by which A. fumi-
gatus attenuates host immune response via distinct means. Mono-
cytic phagocytosis of A. fumigatus conidia results in an attenuated
proinflammatory IL-1b and IL-6 response via TLR2 likely secondary
to depletion of surface TLR2. TLR4 modulation by conidia though,
affects transcription processes upstream independent of phagocy-
tosis. Induction of proinflammatory cytokines TNF and IL-1b/IL-6
by A. fumigatus purportedly involved distinct pathways.
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Background: Bloodstream infection (BSI) by Gram-negative organ-
isms (GNR) occurs in approximately 20% of allogenic hemopoi-
etic stem cell transplant recipients (HSCT). Toll-like receptor
4 (TLR4), has been shown to be a major recognition receptor
for Gram-negative pathogens and specifically lipopolysaccharide
(LPS). The missense mutations TLR4Asp299Gly and co-segregating
TLR4 Thr399Ile are found in approximately 6-10% of Caucasians.
Heterozygosity for TLR4 Asp299Gly TLR4 is associated with hypo-
responsiveness to LPS. We followed prospectively a cohort of 105
allogeneic HSCT to study the association of TLR4Asp299Gly and
Thr399Ile in the donor or recipient with mutations with GNR BSI
after HSCT.
Methods: The study was approved by the MSKCC Institutional Re-
view Board. Patients were followed up to onset of BSI, death or
end of study, whichever occurred first. DNA for donor and recipient
was extracted from whole blood. TLR4 genotyping was performed
by direct sequencing. Genotypes were tabulated as presence or ab-
sence of the minor allele at each locus, separately for the donors
and recipients. “Risk genotype” was defined as heterozygous at
TLR4 299AspGly and Thr399Ile. The cumulative incidence of infec-
tion was estimated by treating death prior to the onset of infection
as a competing risk event, and compared between relevant groups
using a modified chi-squared test.
Results: Ten of 95 (10.5%) donors and 8/88 (9.1%) recipients had
the risk genotype. Twenty-one out of 105 (20%) patients developed
BSI at 1-381 days post transplant. Twenty-seven percent (27%) of
patients with BSI had donor risk genotype compared to 6.4% of pa-
tients without BSI (p=0.01). In contrast, examination of recipient
genotypes showed similar frequencies of “risk genotype” among
patients with or without BSI (5.5% versus 8.5%, p-value = 0.59) (Ta-
ble 1). The cumulative incidence of infection was higher for pa-
tients with donor with risk genotype to patients without risk geno-
type. In contrast, when recipient genotypes were examined the
cumulative incidence of BSI was similar between the two groups
(Figure 1).
Table 1
TLR4 Genotype GNR BSI P-value
Yes No
N (%) N (%)
Donor Risk genotype 5 (27.7) 5 (6.4)
No risk genotype 13 (72.3) 72 (93.6) 0.01
Total 18 (100) 77 (100)
Recipient Risk genotype 17 (94.5) 64 (91.5) 0.59
No risk genotype 1 ( 5.5) 6 (8.5)
Total 18 (100) 70 (100)
Figure 1. Cumulative incidence of Gram-negative BSI or mortality without
BSI by donor type.
Conclusions: This is the first prospective study suggesting an as-
sociation of TLR4 polymorphisms with Gram-negative bloodstream
infection after allogeneic HSCT. The ability to predict genetic sus-
ceptibility to a common infection with substantial morbidity is of
direct relevance to the design of strategies to protect most vulner-
able patients.
